ORPH Stock Price, News & Analysis
Company Description
ORPH (NASDAQ: ORPH) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $37.3M.
ORPH stock has declined 90.6% over the past year.
This page provides a comprehensive overview of ORPH stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ORPH (ORPH) stock. Over the past 12 months, the stock has lost 90.6%. At a market capitalization of $37.3M, ORPH is classified as a micro-cap stock with approximately 35.3M shares outstanding.
Latest News
ORPH has 7 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 5 with negative movement. Key topics include fda approval, clinical trial. View all ORPH news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ORPH Company Profile & Sector Positioning
ORPH (ORPH) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing ORPH often look at related companies in the same sector, including LAVA Therapeutics N.V. (LVTX), Klotho Neurosciences, Inc. (KLTO), Xilio Therapeutics, Inc. (XLO), Mersana Therapeutics Inc (MRSN), and LakeShore Biopharma Co., Ltd (LSB). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ORPH's relative position within its industry.